TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Ibd
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Adults and children (age 2 or older) with a diagnosis of Crohn’s disease (CD), ulcerative colitis (UC), or Indeterminate colitis (IBDU) having been prescribed any IBD treatment (initial or subsequent) outside of a clinical trial.
    2. Have plans for future visits at the site for continued management of IBD.

You may not be eligible for this study if the following are true:

    1. Inability to provide written informed consent/assent.
    2. Being enrolled in any interventional study or trial for IBD treatment. Note: Patient may be enrolled in other registries or studies where IBD treatment outcomes are observed and/or reported (such as center-based registries).
    3. Prior total abdominal colectomy for UC or IBDU.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.